| Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study S de Lusignan, J Dorward, A Correa, N Jones, O Akinyemi, ... The Lancet Infectious Diseases 20 (9), 1034-1042, 2020 | 722 | 2020 |
| Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform … CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman, G Hayward, ... The Lancet 401 (10373), 281-293, 2023 | 381 | 2023 |
| Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville, O Gbinigie, ... The Lancet 398 (10303), 843-855, 2021 | 331 | 2021 |
| Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label … CC Butler, J Dorward, LM Yu, O Gbinigie, G Hayward, BR Saville, ... The Lancet 397 (10279), 1063-1074, 2021 | 323 | 2021 |
| The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis J Dorward, T Khubone, K Gate, H Ngobese, Y Sookrajh, S Mkhize, ... The lancet HIV 8 (3), e158-e165, 2021 | 303* | 2021 |
| Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response PK Drain, J Dorward, A Bender, L Lillis, F Marinucci, J Sacks, A Bershteyn, ... Clinical microbiology reviews 32 (3), 10.1128/cmr. 00097-18, 2019 | 123 | 2019 |
| Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research J Dorward, R Lessells, PK Drain, K Naidoo, T de Oliveira, Y Pillay, ... The lancet HIV 5 (7), e400-e404, 2018 | 117* | 2018 |
| Developing oligodendrocytes express functional GABAB receptors that stimulate cell proliferation and migration K Luyt, TP Slade, JJ Dorward, CF Durant, Y Wu, R Shigemoto, SJ Mundell, ... Journal of neurochemistry 100 (3), 822-840, 2007 | 117 | 2007 |
| Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial PK Drain, J Dorward, LR Violette, J Quame-Amaglo, KK Thomas, ... The lancet HIV 7 (4), e229-e237, 2020 | 101 | 2020 |
| Risk of adverse coronavirus disease 2019 outcomes for people living with HIV MM Mellor, AC Bast, NR Jones, NW Roberts, JM Ordóñez-Mena, ... Aids 35 (4), F1-F10, 2021 | 100 | 2021 |
| Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive … CC Butler, LM Yu, J Dorward, O Gbinigie, G Hayward, BR Saville, ... The Lancet Respiratory Medicine 9 (9), 1010-1020, 2021 | 82 | 2021 |
| The Oxford Royal College of general practitioners clinical informatics digital hub: protocol to develop extended COVID-19 surveillance and trial platforms S de Lusignan, N Jones, J Dorward, R Byford, H Liyanage, J Briggs, ... JMIR public health and surveillance 6 (3), e19773, 2020 | 71 | 2020 |
| Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known … M Joy, FDR Hobbs, JL Bernal, J Sherlock, G Amirthalingam, D McGagh, ... British Journal of General Practice 70 (701), e890-e898, 2020 | 65 | 2020 |
| Point-of-care viral load testing and differentiated HIV care J Dorward, PK Drain, N Garrett The lancet. HIV 5 (1), e8, 2018 | 56 | 2018 |
| Clinic flow for STI, HIV, and TB patients in an urban infectious disease clinic offering point-of-care testing services in Durban, South Africa KJ Stime, N Garrett, Y Sookrajh, J Dorward, N Dlamini, A Olowolagba, ... BMC health services research 18, 1-9, 2018 | 51 | 2018 |
| Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial J Dorward, LM Yu, G Hayward, BR Saville, O Gbinigie, O Van Hecke, ... British Journal of General Practice 72 (720), e446-e455, 2022 | 47 | 2022 |
| Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study N Garrett, N Mitchev, F Osman, J Naidoo, J Dorward, R Singh, H Ngobese, ... BMJ open 9 (2), e026888, 2019 | 45 | 2019 |
| The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review J Dorward, O Gbinigie, T Cai, NW Roberts, N Garrett, G Hayward, ... Antiviral therapy 25 (7), 365-376, 2020 | 44* | 2020 |
| Understanding how community antiretroviral delivery influences engagement in HIV care: a qualitative assessment of the Centralised Chronic Medication Dispensing and … J Dorward, L Msimango, A Gibbs, H Shozi, S Tonkin-Crine, G Hayward, ... BMJ open 10 (5), e035412, 2020 | 41 | 2020 |
| Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa K Simeon, M Sharma, J Dorward, J Naidoo, N Dlamini, P Moodley, ... PloS one 14 (10), e0223669, 2019 | 41 | 2019 |
